Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "nasopharyngeal carcinoma"

GrantNIH REPORTERMay 11

New NIH Grant: 2026 Nasopharyngeal Carcinoma Gordon Research Conference — $15K at Unknown Institution

The National Institutes of Health is funding a scientific conference in May 2026 focused on nasopharyngeal carcinoma (NPC), a rare cancer that starts in the back of the nose and throat. This cancer is particularly common in certain regions like Alaska and affects people in their 40s, much earlier than most other cancers. Researchers will gather to discuss how genetics, viruses, and other factors cause this disease and how to treat it better.

WHY IT MATTERSThis conference will bring together leading NPC researchers to advance understanding of why this cancer develops earlier in life and disproportionately affects certain populations, potentially leading to better screening and treatment options for affected patients.
Good to knownasopharyngeal carcinoma

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases